Crispr Therapeutics AG (CRSP): A New Gene-Editing Technique May Be Able...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	63
Posts	8502
Boards Moderated	0
Alias Born	01/10/2014

Timetravelerdos

Re: None

Wednesday, 01/06/2021 12:24:11 PM

Wednesday, January 06, 2021 12:24:11 PM

A New Gene-Editing Technique May Be Able to Help Children Who Prematurely Age!

Base-editing is a variant of the gene-manipulation breakthrough called Crispr-Cas editing whose discovery won the chemistry Nobel Prize in October for the scientists Jennifer Doudna and Emmanuelle Charpentier. The ability of Crispr-Cas molecules to target and disrupt troublesome genes is being developed by companies like Crispr Therapeutics (CRSP), Editas Medicine (EDIT), and Intellia Therapeutics (NTLA).

https://www.barrons.com/articles/a-new-gene-editing-technique-may-be-able-to-help-children-who-prematurely-age-51609948802?siteid=yhoof2

“Believing in negative thoughts is the single greatest obstruction to success.”
Charles F. Glassman

Statements made are only my opinion. Do your own DD in order to make your own investment decisions.